261 related articles for article (PubMed ID: 30643826)
21. Identification of Serum Periostin as a Potential Diagnostic and Prognostic Marker for Colorectal Cancer.
Dong D; Zhang L; Jia L; Ji W; Wang Z; Ren L; Niu R; Zhou Y
Clin Lab; 2018 Jun; 64(6):973-981. PubMed ID: 29945311
[TBL] [Abstract][Full Text] [Related]
22. Circulating midkine in malignant and non-malignant colorectal diseases.
Krzystek-Korpacka M; Diakowska D; Neubauer K; Gamian A
Cytokine; 2013 Oct; 64(1):158-64. PubMed ID: 23899719
[TBL] [Abstract][Full Text] [Related]
23. Investigation of microRNA-155 as a serum diagnostic and prognostic biomarker for colorectal cancer.
Lv ZC; Fan YS; Chen HB; Zhao DW
Tumour Biol; 2015 Mar; 36(3):1619-25. PubMed ID: 25528214
[TBL] [Abstract][Full Text] [Related]
24. Serum miR-21 and miR-92a as biomarkers in the diagnosis and prognosis of colorectal cancer.
Liu GH; Zhou ZG; Chen R; Wang MJ; Zhou B; Li Y; Sun XF
Tumour Biol; 2013 Aug; 34(4):2175-81. PubMed ID: 23625654
[TBL] [Abstract][Full Text] [Related]
25. Circulating fibrinogen to pre-albumin ratio is a promising biomarker for diagnosis of colorectal cancer.
Sun F; Tan YA; Gao QF; Li SQ; Zhang J; Chen QG; Jiang YH; Zhang L; Ying HQ; Wang XZ
J Clin Lab Anal; 2019 Jan; 33(1):e22635. PubMed ID: 30047185
[TBL] [Abstract][Full Text] [Related]
26. Matrix metalloproteinase 2 and tissue inhibitor of matrix metalloproteinases 2 in the diagnosis of colorectal adenoma and cancer patients.
Groblewska M; Mroczko B; Gryko M; Kędra B; Szmitkowski M
Folia Histochem Cytobiol; 2010 Dec; 48(4):564-71. PubMed ID: 21478099
[TBL] [Abstract][Full Text] [Related]
27. Combined identification of long non-coding RNA CCAT1 and HOTAIR in serum as an effective screening for colorectal carcinoma.
Zhao W; Song M; Zhang J; Kuerban M; Wang H
Int J Clin Exp Pathol; 2015; 8(11):14131-40. PubMed ID: 26823726
[TBL] [Abstract][Full Text] [Related]
28. Investigation of cell free BIRC5 mRNA as a serum diagnostic and prognostic biomarker for colorectal cancer.
Wang H; Zhang X; Wang L; Zheng G; Du L; Yang Y; Dong Z; Liu Y; Qu A; Wang C
J Surg Oncol; 2014 May; 109(6):574-9. PubMed ID: 24338523
[TBL] [Abstract][Full Text] [Related]
29. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients.
Wang J; Wang X; Yu F; Chen J; Zhao S; Zhang D; Yu Y; Liu X; Tang H; Peng Z
Int J Clin Exp Pathol; 2015; 8(11):14853-63. PubMed ID: 26823815
[TBL] [Abstract][Full Text] [Related]
30. Clinical and prognostic significance of anisocytosis measured as a red cell distribution width in patients with colorectal cancer.
Kust D; Lucijanic M; Urch K; Samija I; Celap I; Kruljac I; Prpic M; Lucijanic I; Matesa N; Bolanca A
QJM; 2017 Jun; 110(6):361-367. PubMed ID: 28069908
[TBL] [Abstract][Full Text] [Related]
31. Investigation of MicroRNA-21 Expression Levels in Serum and Stool as a Potential Non-Invasive Biomarker for Diagnosis of Colorectal Cancer.
Bastaminejad S; Taherikalani M; Ghanbari R; Akbari A; Shabab N; Saidijam M
Iran Biomed J; 2017 Mar; 21(2):106-13. PubMed ID: 27432735
[TBL] [Abstract][Full Text] [Related]
32. Predictive value of red blood cell distribution width and hematocrit for short-term outcomes and prognosis in colorectal cancer patients undergoing radical surgery.
Peng D; Li ZW; Liu F; Liu XR; Wang CY
World J Gastroenterol; 2024 Mar; 30(12):1714-1726. PubMed ID: 38617745
[TBL] [Abstract][Full Text] [Related]
33. Pretreatment serum levels of hematopoietic cytokines in patients with colorectal adenomas and cancer.
Mroczko B; Szmitkowski M; Wereszczyńska-Siemiatkowska U; Okulczyk B; Kedra B
Int J Colorectal Dis; 2007 Jan; 22(1):33-8. PubMed ID: 16520929
[TBL] [Abstract][Full Text] [Related]
34. Elevated serum level of lncRNA-HIF1A-AS1 as a novel diagnostic predictor for worse prognosis in colorectal carcinoma.
Gong W; Tian M; Qiu H; Yang Z
Cancer Biomark; 2017 Dec; 20(4):417-424. PubMed ID: 28946548
[TBL] [Abstract][Full Text] [Related]
35. Circulating exosomal CPNE3 as a diagnostic and prognostic biomarker for colorectal cancer.
Sun B; Li Y; Zhou Y; Ng TK; Zhao C; Gan Q; Gu X; Xiang J
J Cell Physiol; 2019 Feb; 234(2):1416-1425. PubMed ID: 30078189
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of platelet indices as diagnostic biomarkers for colorectal cancer.
Zhu X; Cao Y; Lu P; Kang Y; Lin Z; Hao T; Song Y
Sci Rep; 2018 Aug; 8(1):11814. PubMed ID: 30087357
[TBL] [Abstract][Full Text] [Related]
37. Relationship between red blood cell distribution width, bilirubin, and clinical characteristics of patients with gastric cancer.
Wei TT; Wang LL; Yin JR; Liu YT; Qin BD; Li JY; Yin X; Zhou L; Zhong RQ
Int J Lab Hematol; 2017 Oct; 39(5):497-501. PubMed ID: 28497572
[TBL] [Abstract][Full Text] [Related]
38. Spalt-like transcription factor 4 as a potential diagnostic and prognostic marker of colorectal cancer.
Wu HK; Liu C; Fan XX; Wang H; Zhou L
Cancer Biomark; 2017 Aug; 20(2):191-198. PubMed ID: 28869451
[TBL] [Abstract][Full Text] [Related]
39. Serum Levels of BDNF in Patients with Adenoma and Colorectal Cancer.
Wang Z; Wang S; Liu Y; Gao S; Yu Y; Hu Z
Dis Markers; 2021; 2021():8867368. PubMed ID: 33628340
[TBL] [Abstract][Full Text] [Related]
40. Preoperative serum carcinoembryonic antigen, carbohydrate antigen19-9 and carbohydrate antigen 125 as prognostic factors for recurrence-free survival in colorectal cancer.
Yang XQ; Chen C; Wang FB; Peng CW; Li Y
Asian Pac J Cancer Prev; 2011; 12(5):1251-6. PubMed ID: 21875276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]